For over three decades, Jingtian & Gongcheng has been rendering best-in-class services and solutions to clients in the health care and life science industry in China. Our comprehensive scope of services permeates the industrial spectrum to include public health, pharmaceuticals, biomedical technology, medical devices, genetic testing and diagnosing, eHealth, elderly care and wellness management.
Our clients include, start-ups, unicorn companies, flagship enterprises, investment banks, industrial funds, and other financial institutions.
As a leading law firm, we have successfully represented clients in numerous deals, some of which have become landmarks of the industry including:
- Listing the first mainland hospital CR Medical in HKEx
- Listing the largest hospital management company IHH, in Singapore and Malaysia
- Listing he first mainland healthcare service company, Concord Medical Services Holdings Limited in NYSE
- Listing of WuXi AppTec, a unicorn company in China's pharmaceutical industry in HKEx
Areas of Work
- Anti-unfair competition and anti-monopoly
- Corporate governance
- Data protection and management,
- Dispute resolution
- Enterprises restructuring
- Intellectual property protection and licensing
- On-shore/off-shore investments
- On-shore/off-shore listing
- Mergers and acquisitions
- Product promotion and marketing authorization
- Regulatory and compliance consultations in daily operation
- Sino-foreign equity/cooperative joint ventures
